Physician profile
John Sharbil Hamati
NPI 1124581020
$14,850.70
in general payments reported to CMS, 2019-2025
25 companies · $5,158 in 2025
The $5,158 reported for 2025 was more than what 92% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $258 · 2020: $203 · 2021: $698 · 2022: $956 · 2023: $2,152 · 2024: $5,425 · 2025: $5,158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,772 · Travel and Lodging: $2,964.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,771.74 |
| Travel and Lodging | $2,963.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $2,868.67 | 2023-2025 | |
| Abbvie INC. | $2,276.20 | 2023-2025 | |
| Stryker Corporation | $1,751.18 | 2023-2025 | 1788, Spy-Phi System |
| Acera Surgical, INC. | $1,414.36 | 2023-2025 | Restrata Wound Matrix |
| Mentor Worldwide LLC | $1,305.28 | 2021-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander, Mentor Cpx 2 Breast Tissue Expander |
| Integra Lifesciences Corporation | $1,191.92 | 2019-2025 | Integra, Durasorb Monofilament Mesh, Integra Dermal Regeneration Template |
| Axogen | $935.45 | 2019-2025 | Avance Nerve Graft, Axoguard Ha+ Nerve Protector, Axoguard Nerve Connector |
| Allergan, INC. | $609.50 | 2021-2022 | |
| Kerecis Limited | $439.22 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen |
| Tela Bio, INC. | $296.90 | 2024 | Ovitex 2s |
| Checkpoint Surgical, INC | $290.13 | 2023-2024 | Checkpoint Stimulators |
| Pacira Pharmaceuticals Incorporated | $178.29 | 2022-2025 | Exparel |
| Polynovo North America LLC | $143.54 | 2023 | |
| Davol INC. | $124.69 | 2022 | |
| Acumed LLC | $121.96 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $121.86 | 2025 | Aponvie, Zynrelef |
| Zimmer Biomet Holdings, INC. | $118.19 | 2025 | |
| Ethicon US, LLC | $116.42 | 2024 | Surgicel Nu-Knit, Dermabond, Stratafix |
| Baxter Healthcare | $108.69 | 2019 | |
| Kci USA, INC. | $108.52 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $104.32 | 2025 | |
| Motiva USA, LLC | $103.00 | 2025 | |
| Medline Industries LP | $75.15 | 2020-2021 | |
| Depuy Synthes Sales INC. | $25.70 | 2025 | Na |
| Revance Therapeutics, INC. | $21.56 | 2025 | Daxxify |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Hamati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.